These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 37108478)

  • 21. Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids.
    Matthews AL; Noy PJ; Reyat JS; Tomlinson MG
    Platelets; 2017 Jun; 28(4):333-341. PubMed ID: 27256961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential?
    Saftig P; Reiss K
    Eur J Cell Biol; 2011; 90(6-7):527-35. PubMed ID: 21194787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
    Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
    Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells.
    Ebsen H; Schröder A; Kabelitz D; Janssen O
    PLoS One; 2013; 8(10):e76853. PubMed ID: 24130797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulated release and functional activity of surface expressed metalloproteinase ADAM17 in exosomes.
    Groth E; Pruessmeyer J; Babendreyer A; Schumacher J; Pasqualon T; Dreymueller D; Higashiyama S; Lorenzen I; Grötzinger J; Cataldo D; Ludwig A
    Biochim Biophys Acta; 2016 Nov; 1863(11):2795-2808. PubMed ID: 27599715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer.
    Pruessmeyer J; Ludwig A
    Semin Cell Dev Biol; 2009 Apr; 20(2):164-74. PubMed ID: 18951988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteolytic processing of PD-L1 by ADAM proteases in breast cancer cells.
    Romero Y; Wise R; Zolkiewska A
    Cancer Immunol Immunother; 2020 Jan; 69(1):43-55. PubMed ID: 31796994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoglycan (PODXL2) is proteolytically processed by ADAM10 (a disintegrin and metalloprotease 10) and controls neurite branching in primary neurons.
    Hsia HE; Tüshaus J; Feng X; Hofmann LI; Wefers B; Marciano DK; Wurst W; Lichtenthaler SF
    FASEB J; 2021 Sep; 35(9):e21813. PubMed ID: 34390512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
    Araya HF; Sepulveda H; Lizama CO; Vega OA; Jerez S; Briceño PF; Thaler R; Riester SM; Antonelli M; Salazar-Onfray F; Rodríguez JP; Moreno RD; Montecino M; Charbonneau M; Dubois CM; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Biochem; 2018 Nov; 119(10):8204-8219. PubMed ID: 29923217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MT1-MMP and ADAM10/17 exhibit a remarkable overlap of shedding properties.
    Werny L; Grogro A; Bickenbach K; Bülck C; Armbrust F; Koudelka T; Pathak K; Scharfenberg F; Sammel M; Sheikhouny F; Tholey A; Linder S; Becker-Pauly C
    FEBS J; 2023 Jan; 290(1):93-111. PubMed ID: 35944080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries.
    Tucher J; Linke D; Koudelka T; Cassidy L; Tredup C; Wichert R; Pietrzik C; Becker-Pauly C; Tholey A
    J Proteome Res; 2014 Apr; 13(4):2205-14. PubMed ID: 24635658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling.
    Bozkulak EC; Weinmaster G
    Mol Cell Biol; 2009 Nov; 29(21):5679-95. PubMed ID: 19704010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TLR4-mediated galectin-1 production triggers epithelial-mesenchymal transition in colon cancer cells through ADAM10- and ADAM17-associated lactate production.
    Park GB; Kim D
    Mol Cell Biochem; 2017 Jan; 425(1-2):191-202. PubMed ID: 27837433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression profile of ADAM10 and ADAM17 in allergic rhinitis.
    Chueh HW; Park SK; Hur DY; Bae WY
    Int Forum Allergy Rhinol; 2015 Nov; 5(11):1036-41. PubMed ID: 26250527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The transmembrane domain of the amyloid precursor protein is required for antiamyloidogenic processing by α-secretase ADAM10.
    Hitschler L; Lang T
    J Biol Chem; 2022 Jun; 298(6):101911. PubMed ID: 35398353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukocytes require ADAM10 but not ADAM17 for their migration and inflammatory recruitment into the alveolar space.
    Pruessmeyer J; Hess FM; Alert H; Groth E; Pasqualon T; Schwarz N; Nyamoya S; Kollert J; van der Vorst E; Donners M; Martin C; Uhlig S; Saftig P; Dreymueller D; Ludwig A
    Blood; 2014 Jun; 123(26):4077-88. PubMed ID: 24833351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADAM10 and ADAM17-Novel Players in Retinoblastoma Carcinogenesis.
    Van Meenen D; Doege A; Alefeld E; Haase A; Beier M; Kiefer T; Biewald E; Metz K; Dräger O; Busch MA; Dünker N
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts.
    Mezyk-Kopeć R; Bzowska M; Stalińska K; Chełmicki T; Podkalicki M; Jucha J; Kowalczyk K; Mak P; Bereta J
    Cytokine; 2009 Jun; 46(3):309-15. PubMed ID: 19346138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased expression of ADAM10 on monocytes is associated with chronic allograft dysfunction in kidney transplant recipients.
    Li Y; Bai Y; Zhang H; Li Y; Yan L; Wang X; Fan J; An Y; Wan Z; Hu S; Wang L; Shi Y
    Int Immunopharmacol; 2023 Feb; 115():109710. PubMed ID: 36652757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unsaturated fatty acids drive disintegrin and metalloproteinase (ADAM)-dependent cell adhesion, proliferation, and migration by modulating membrane fluidity.
    Reiss K; Cornelsen I; Husmann M; Gimpl G; Bhakdi S
    J Biol Chem; 2011 Jul; 286(30):26931-42. PubMed ID: 21642425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.